The Lipidomic Profile Is Associated with the Dietary Pattern in Subjects with and without Diabetes Mellitus from a Mediterranean Area.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
08 Jun 2024
Historique:
received: 09 05 2024
revised: 31 05 2024
accepted: 05 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Lipid functions can be influenced by genetics, age, disease states, and lifestyle factors, particularly dietary patterns, which are crucial in diabetes management. Lipidomics is an expanding field involving the comprehensive exploration of lipids from biological samples. In this cross-sectional study, 396 participants from a Mediterranean region, including individuals with type 1 diabetes (T1D), type 2 diabetes (T2D), and non-diabetic individuals, underwent lipidomic profiling and dietary assessment. Participants completed validated food frequency questionnaires, and lipid analysis was conducted using ultra-high-performance liquid chromatography coupled with mass spectrometry (UHPLC/MS). Multiple linear regression models were used to determine the association between lipid features and dietary patterns. Across all subjects, acylcarnitines (AcCa) and triglycerides (TG) displayed negative associations with the alternate Healthy Eating Index (aHEI), indicating a link between lipidomic profiles and dietary habits. Various lipid species (LS) showed positive and negative associations with dietary carbohydrates, fats, and proteins. Notably, in the interaction analysis between diabetes and the aHEI, we found some lysophosphatidylcholines (LPC) that showed a similar direction with respect to aHEI in non-diabetic individuals and T2D subjects, while an opposite direction was observed in T1D subjects. The study highlights the significant association between lipidomic profiles and dietary habits in people with and without diabetes, particularly emphasizing the role of healthy dietary choices, as reflected by the aHEI, in modulating lipid concentrations. These findings underscore the importance of dietary interventions to improve metabolic health outcomes, especially in the context of diabetes management.

Identifiants

pubmed: 38931159
pii: nu16121805
doi: 10.3390/nu16121805
pii:
doi:

Substances chimiques

Lipids 0
acylcarnitine 0
Triglycerides 0
Carnitine S7UI8SM58A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Spanish Ministry of Health, Instituto de Salud Carlos III
ID : PI15/0625
Organisme : Spanish Ministry of Health, Instituto de Salud Carlos III
ID : PI18/0328
Organisme : CIBER-Consorcio Centro de Investigación Biomédica en Red
ID : CB15/00071
Organisme : Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021-2024 of Generalitat de Catalunya
ID : SLT017/20/000107
Organisme : Miguel Servet Type 2 contract, ISCIII
ID : CPII18/00004

Auteurs

Marina Idalia Rojo-López (MI)

Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.

Maria Barranco-Altirriba (M)

Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
B2SLab, Departament d'Enginyeria de Sistemes, Automàtica i Informàtica Industrial, Universitat Politècnica de Catalunya, 08028 Barcelona, Spain.
Networking Biomedical Research Centre in the Subject Area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029 Barcelona, Spain.

Joana Rossell (J)

Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Maria Antentas (M)

Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.

Esmeralda Castelblanco (E)

Department of Internal Medicine, Endocrinology, Metabolism and Lipid Research Division, Washington University School of Medicine, St. Louis, MO 63110, USA.

Oscar Yanes (O)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Electronic Engineering, Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili, 43007 Tarragona, Spain.

Ralf J M Weber (RJM)

School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

Gavin R Lloyd (GR)

School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

Catherine Winder (C)

School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Centre for Metabolomics Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.

Warwick B Dunn (WB)

School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Centre for Metabolomics Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.

Josep Julve (J)

Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Minerva Granado-Casas (M)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.
Research Group of Health Care (GreCS), IRBLleida, 25198 Lleida, Spain.

Dídac Mauricio (D)

Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Faculty of Medicine, University of Vic (UVIC/UCC), 08500 Vic, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH